BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 26842886)

  • 1. Solution-State Structure and Affinities of Cyclodextrin:Fentanyl Complexes by Nuclear Magnetic Resonance Spectroscopy and Molecular Dynamics Simulation.
    Mayer BP; Kennedy DJ; Lau EY; Valdez CA
    J Phys Chem B; 2016 Mar; 120(9):2423-33. PubMed ID: 26842886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of fentanyl with various cyclodextrins in aqueous solutions.
    Ogawa N; Furuishi T; Nagase H; Endo T; Takahashi C; Yamamoto H; Kawashima Y; Loftsson T; Kobayashi M; Ueda H
    J Pharm Pharmacol; 2016 May; 68(5):588-97. PubMed ID: 26077960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of polyanionic cyclodextrins as high affinity binding scaffolds for fentanyl.
    Mayer BP; Kennedy DJ; Lau EY; Valdez CA
    Sci Rep; 2023 Feb; 13(1):2680. PubMed ID: 36792632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dynamics simulations of UC781-cyclodextrins inclusion complexes in aqueous solution.
    Boonyarattanakalin K; Wolschann P; Toochinda P; Lawtrakul L
    Eur J Pharm Sci; 2012 Nov; 47(4):752-8. PubMed ID: 22922099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, spectroscopy and molecular modelling studies of the inclusion complex of cordycepin with cyclodextrins.
    Zhang JQ; Wu D; Jiang KM; Zhang D; Zheng X; Wan CP; Zhu HY; Xie XG; Jin Y; Lin J
    Carbohydr Res; 2015 Apr; 406():55-64. PubMed ID: 25679304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the complexation of risperidone and 9-hydroxyrisperidone with cyclodextrin hosts using affinity capillary electrophoresis and (1)H NMR spectroscopy.
    Danel C; Azaroual N; Brunel A; Lannoy D; Vermeersch G; Odou P; Vaccher C
    J Chromatogr A; 2008 Dec; 1215(1-2):185-93. PubMed ID: 19013582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical studies on inclusion complexes of cyclodextrins.
    Nagaraju M; Sastry GN
    J Phys Chem A; 2009 Aug; 113(34):9533-42. PubMed ID: 19655710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inclusion complexes of PBN-type nitrone spin traps and their superoxide spin adducts with cyclodextrin derivatives: parallel determination of the association constants by NMR titrations and 2D-EPR simulations.
    Bardelang D; Rockenbauer A; Karoui H; Finet JP; Tordo P
    J Phys Chem B; 2005 May; 109(20):10521-30. PubMed ID: 16852274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cogrinding with β-cyclodextrin on the solid state fentanyl.
    Ogawa N; Higashi K; Nagase H; Endo T; Moribe K; Loftsson T; Yamamoto K; Ueda H
    J Pharm Sci; 2010 Dec; 99(12):5019-29. PubMed ID: 20821388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of nuclear magnetic resonance spectroscopy to characterize the structure of dexamethasone sodium phosphate inclusion complexes with cyclodextrins in solution and to analyze potential competitive effects.
    Echezarreta-López MM; Perdomo-López I; Estrada E; Vila-Jato JL; Torres-Labandeira JJ
    J Pharm Sci; 2002 Jun; 91(6):1536-47. PubMed ID: 12115852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inclusion complex formation of captopril with alpha- and beta-cyclodextrins in aqueous solution: NMR spectroscopic and molecular dynamic studies.
    Ikeda Y; Motoune S; Matsuoka T; Arima H; Hirayama F; Uekama K
    J Pharm Sci; 2002 Nov; 91(11):2390-8. PubMed ID: 12379924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR spectroscopic characterization of metoprolol/cyclodextrin complexes in aqueous solution: cavity size dependency.
    Ikeda Y; Hirayama F; Arima H; Uekama K; Yoshitake Y; Harano K
    J Pharm Sci; 2004 Jul; 93(7):1659-71. PubMed ID: 15176056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative proton nuclear magnetic resonance studies of amantadine complexes formed in aqueous solutions with three major cyclodextrins.
    Lis-Cieplak A; Sitkowski J; Kolodziejski W
    J Pharm Sci; 2014 Jan; 103(1):274-82. PubMed ID: 24282085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aggregation of cyclodextrins as an important factor to determine their complexation behavior.
    Bikádi Z; Kurdi R; Balogh S; Szemán J; Hazai E
    Chem Biodivers; 2006 Nov; 3(11):1266-78. PubMed ID: 17193241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
    Zheng Y; Haworth IS; Zuo Z; Chow MS; Chow AH
    J Pharm Sci; 2005 May; 94(5):1079-89. PubMed ID: 15793810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cyclodextrins on the aqueous solubility of a new MMP inhibitor: phase solubility, 1 H-NMR spectroscopy and molecular modeling studies, preparation and stability study of nebulizable solutions.
    Bertholet P; Gueders M; Dive G; Albert A; Barillaro V; Perly B; Cataldo D; Piel G; Delattre L; Evrard B
    J Pharm Pharm Sci; 2005 Jul; 8(2):163-74. PubMed ID: 16124927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of capillary electrophoresis, molecular modeling and NMR to study the enantioselective complexation of sulpiride with double cyclodextrin systems.
    Melani F; Pasquini B; Caprini C; Gotti R; Orlandini S; Furlanetto S
    J Pharm Biomed Anal; 2015 Oct; 114():265-71. PubMed ID: 26092223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear magnetic resonance investigation of the stoichiometries in beta-cyclodextrin:steroid inclusion complexes.
    Djedaïni F; Perly B
    J Pharm Sci; 1991 Dec; 80(12):1157-61. PubMed ID: 1815075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclodextrin complexation studies as the first step for repurposing of chlorpromazine.
    Wang Z; Landy D; Sizun C; Cézard C; Solgadi A; Przybylski C; de Chaisemartin L; Herfindal L; Barratt G; Legrand FX
    Int J Pharm; 2020 Jun; 584():119391. PubMed ID: 32376444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation.
    Chi L; Liu R; Guo T; Wang M; Liao Z; Wu L; Li H; Wu D; Zhang J
    Int J Pharm; 2015 Feb; 479(2):349-56. PubMed ID: 25575474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.